Ichor Holdings, Ltd. (ICHR) Stock Competitors & Peer Comparison

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, NVDA has a market cap of 5T. Regarding current trading prices, ICHR is priced at $72.58, while NVDA trades at $202.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas NVDA's P/E ratio is 31.93. In terms of profitability, ICHR's ROE is -0.08%, compared to NVDA's ROE of +1.12%. Regarding short-term risk, ICHR is more volatile compared to NVDA. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check NVDA's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, TSM has a market cap of 2.2T. Regarding current trading prices, ICHR is priced at $72.58, while TSM trades at $412.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas TSM's P/E ratio is 36.73. In terms of profitability, ICHR's ROE is -0.08%, compared to TSM's ROE of +0.37%. Regarding short-term risk, ICHR is more volatile compared to TSM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check TSM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AVGO has a market cap of 1.9T. Regarding current trading prices, ICHR is priced at $72.58, while AVGO trades at $374.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AVGO's P/E ratio is 65.03. In terms of profitability, ICHR's ROE is -0.08%, compared to AVGO's ROE of +0.36%. Regarding short-term risk, ICHR is more volatile compared to AVGO. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AVGO's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MU has a market cap of 1.1T. Regarding current trading prices, ICHR is priced at $72.58, while MU trades at $898.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MU's P/E ratio is 44.21. In terms of profitability, ICHR's ROE is -0.08%, compared to MU's ROE of +0.41%. Regarding short-term risk, ICHR is more volatile compared to MU. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MU's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AMD has a market cap of 775.4B. Regarding current trading prices, ICHR is priced at $72.58, while AMD trades at $456.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AMD's P/E ratio is 159.57. In terms of profitability, ICHR's ROE is -0.08%, compared to AMD's ROE of +0.08%. Regarding short-term risk, ICHR is more volatile compared to AMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AMD's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ASML has a market cap of 685.2B. Regarding current trading prices, ICHR is priced at $72.58, while ASML trades at $1,738.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ASML's P/E ratio is 59.18. In terms of profitability, ICHR's ROE is -0.08%, compared to ASML's ROE of +0.52%. Regarding short-term risk, ICHR is more volatile compared to ASML. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ASML's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, INTC has a market cap of 542.4B. Regarding current trading prices, ICHR is priced at $72.58, while INTC trades at $106.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas INTC's P/E ratio is -179.87. In terms of profitability, ICHR's ROE is -0.08%, compared to INTC's ROE of -0.03%. Regarding short-term risk, ICHR is more volatile compared to INTC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check INTC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, LRCX has a market cap of 409.1B. Regarding current trading prices, ICHR is priced at $72.58, while LRCX trades at $323.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas LRCX's P/E ratio is 61.96. In terms of profitability, ICHR's ROE is -0.08%, compared to LRCX's ROE of +0.66%. Regarding short-term risk, ICHR is more volatile compared to LRCX. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check LRCX's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AMAT has a market cap of 396.4B. Regarding current trading prices, ICHR is priced at $72.58, while AMAT trades at $498.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AMAT's P/E ratio is 46.87. In terms of profitability, ICHR's ROE is -0.08%, compared to AMAT's ROE of +0.40%. Regarding short-term risk, ICHR is more volatile compared to AMAT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AMAT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ARM has a market cap of 345.7B. Regarding current trading prices, ICHR is priced at $72.58, while ARM trades at $308.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ARM's P/E ratio is 377.74. In terms of profitability, ICHR's ROE is -0.08%, compared to ARM's ROE of +0.12%. Regarding short-term risk, ICHR is more volatile compared to ARM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ARM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, KLAC has a market cap of 279.5B. Regarding current trading prices, ICHR is priced at $72.58, while KLAC trades at $2,138.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas KLAC's P/E ratio is 60.78. In terms of profitability, ICHR's ROE is -0.08%, compared to KLAC's ROE of +0.89%. Regarding short-term risk, ICHR is more volatile compared to KLAC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check KLAC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, TXN has a market cap of 262.7B. Regarding current trading prices, ICHR is priced at $72.58, while TXN trades at $284.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas TXN's P/E ratio is 49.42. In terms of profitability, ICHR's ROE is -0.08%, compared to TXN's ROE of +0.32%. Regarding short-term risk, ICHR is more volatile compared to TXN. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check TXN's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MRVL has a market cap of 233.5B. Regarding current trading prices, ICHR is priced at $72.58, while MRVL trades at $255.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MRVL's P/E ratio is 92.03. In terms of profitability, ICHR's ROE is -0.08%, compared to MRVL's ROE of +0.17%. Regarding short-term risk, ICHR is more volatile compared to MRVL. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MRVL's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, QCOM has a market cap of 216.5B. Regarding current trading prices, ICHR is priced at $72.58, while QCOM trades at $193.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas QCOM's P/E ratio is 22.09. In terms of profitability, ICHR's ROE is -0.08%, compared to QCOM's ROE of +0.40%. Regarding short-term risk, ICHR is more volatile compared to QCOM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check QCOM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ADI has a market cap of 197.1B. Regarding current trading prices, ICHR is priced at $72.58, while ADI trades at $395.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ADI's P/E ratio is 60.39. In terms of profitability, ICHR's ROE is -0.08%, compared to ADI's ROE of +0.10%. Regarding short-term risk, ICHR is more volatile compared to ADI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ADI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ASX has a market cap of 77.1B. Regarding current trading prices, ICHR is priced at $72.58, while ASX trades at $34.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ASX's P/E ratio is 52.48. In terms of profitability, ICHR's ROE is -0.08%, compared to ASX's ROE of +0.14%. Regarding short-term risk, ICHR is more volatile compared to ASX. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ASX's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MPWR has a market cap of 75.3B. Regarding current trading prices, ICHR is priced at $72.58, while MPWR trades at $1,478.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MPWR's P/E ratio is 110.06. In terms of profitability, ICHR's ROE is -0.08%, compared to MPWR's ROE of +0.19%. Regarding short-term risk, ICHR is more volatile compared to MPWR. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MPWR's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, NXPI has a market cap of 75.1B. Regarding current trading prices, ICHR is priced at $72.58, while NXPI trades at $287.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas NXPI's P/E ratio is 28.46. In terms of profitability, ICHR's ROE is -0.08%, compared to NXPI's ROE of +0.26%. Regarding short-term risk, ICHR is more volatile compared to NXPI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check NXPI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, STM has a market cap of 65.2B. Regarding current trading prices, ICHR is priced at $72.58, while STM trades at $70.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas STM's P/E ratio is 458.41. In terms of profitability, ICHR's ROE is -0.08%, compared to STM's ROE of +0.01%. Regarding short-term risk, ICHR is more volatile compared to STM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check STM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ALAB has a market cap of 58.6B. Regarding current trading prices, ICHR is priced at $72.58, while ALAB trades at $335.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ALAB's P/E ratio is 229.33. In terms of profitability, ICHR's ROE is -0.08%, compared to ALAB's ROE of +0.20%. Regarding short-term risk, ICHR is more volatile compared to ALAB. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ALAB's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, TER has a market cap of 57.8B. Regarding current trading prices, ICHR is priced at $72.58, while TER trades at $349.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas TER's P/E ratio is 68.37. In terms of profitability, ICHR's ROE is -0.08%, compared to TER's ROE of +0.30%. Regarding short-term risk, ICHR is more volatile compared to TER. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check TER's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, CBRS has a market cap of 49.8B. Regarding current trading prices, ICHR is priced at $72.58, while CBRS trades at $240.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas CBRS's P/E ratio is 540.04. In terms of profitability, ICHR's ROE is -0.08%, compared to CBRS's ROE of +1.23%. Regarding short-term risk, ICHR is more volatile compared to CBRS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check CBRS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, UMC has a market cap of 49.6B. Regarding current trading prices, ICHR is priced at $72.58, while UMC trades at $18.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas UMC's P/E ratio is 31.58. In terms of profitability, ICHR's ROE is -0.08%, compared to UMC's ROE of +0.14%. Regarding short-term risk, ICHR is more volatile compared to UMC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check UMC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MCHP has a market cap of 49.6B. Regarding current trading prices, ICHR is priced at $72.58, while MCHP trades at $88.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MCHP's P/E ratio is 415.77. In terms of profitability, ICHR's ROE is -0.08%, compared to MCHP's ROE of +0.03%. Regarding short-term risk, ICHR is more volatile compared to MCHP. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MCHP's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ON has a market cap of 45.9B. Regarding current trading prices, ICHR is priced at $72.58, while ON trades at $109.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ON's P/E ratio is 86.03. In terms of profitability, ICHR's ROE is -0.08%, compared to ON's ROE of +0.07%. Regarding short-term risk, ICHR is more volatile compared to ON. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ON's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, GFS has a market cap of 41.3B. Regarding current trading prices, ICHR is priced at $72.58, while GFS trades at $73.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas GFS's P/E ratio is 50.85. In terms of profitability, ICHR's ROE is -0.08%, compared to GFS's ROE of +0.07%. Regarding short-term risk, ICHR is more volatile compared to GFS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check GFS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, Q has a market cap of 30.3B. Regarding current trading prices, ICHR is priced at $72.58, while Q trades at $138.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas Q's P/E ratio is 46.71. In terms of profitability, ICHR's ROE is -0.08%, compared to Q's ROE of +0.08%. Regarding short-term risk, ICHR is more volatile compared to Q. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check Q's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MTSI has a market cap of 27.4B. Regarding current trading prices, ICHR is priced at $72.58, while MTSI trades at $349.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MTSI's P/E ratio is 152.65. In terms of profitability, ICHR's ROE is -0.08%, compared to MTSI's ROE of +0.13%. Regarding short-term risk, ICHR is more volatile compared to MTSI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MTSI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, TSEM has a market cap of 25.5B. Regarding current trading prices, ICHR is priced at $72.58, while TSEM trades at $221.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas TSEM's P/E ratio is 102.28. In terms of profitability, ICHR's ROE is -0.08%, compared to TSEM's ROE of +0.09%. Regarding short-term risk, ICHR is more volatile compared to TSEM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check TSEM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ENTG has a market cap of 20.5B. Regarding current trading prices, ICHR is priced at $72.58, while ENTG trades at $129.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ENTG's P/E ratio is 77.66. In terms of profitability, ICHR's ROE is -0.08%, compared to ENTG's ROE of +0.07%. Regarding short-term risk, ICHR is more volatile compared to ENTG. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ENTG's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, LSCC has a market cap of 18.8B. Regarding current trading prices, ICHR is priced at $72.58, while LSCC trades at $132.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas LSCC's P/E ratio is 982.57. In terms of profitability, ICHR's ROE is -0.08%, compared to LSCC's ROE of +0.03%. Regarding short-term risk, ICHR is more volatile compared to LSCC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check LSCC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AMKR has a market cap of 17.6B. Regarding current trading prices, ICHR is priced at $72.58, while AMKR trades at $69.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AMKR's P/E ratio is 40.75. In terms of profitability, ICHR's ROE is -0.08%, compared to AMKR's ROE of +0.10%. Regarding short-term risk, ICHR is more volatile compared to AMKR. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AMKR's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SITM has a market cap of 17.4B. Regarding current trading prices, ICHR is priced at $72.58, while SITM trades at $652.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SITM's P/E ratio is -701.62. In terms of profitability, ICHR's ROE is -0.08%, compared to SITM's ROE of -0.02%. Regarding short-term risk, ICHR is more volatile compared to SITM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SITM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, NVMI has a market cap of 16.4B. Regarding current trading prices, ICHR is priced at $72.58, while NVMI trades at $501.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas NVMI's P/E ratio is 64.47. In terms of profitability, ICHR's ROE is -0.08%, compared to NVMI's ROE of +0.21%. Regarding short-term risk, ICHR is more volatile compared to NVMI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check NVMI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, RMBS has a market cap of 15.9B. Regarding current trading prices, ICHR is priced at $72.58, while RMBS trades at $138.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas RMBS's P/E ratio is 69.59. In terms of profitability, ICHR's ROE is -0.08%, compared to RMBS's ROE of +0.17%. Regarding short-term risk, ICHR is more volatile compared to RMBS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check RMBS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SMTC has a market cap of 14.7B. Regarding current trading prices, ICHR is priced at $72.58, while SMTC trades at $154.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SMTC's P/E ratio is -384.20. In terms of profitability, ICHR's ROE is -0.08%, compared to SMTC's ROE of -0.06%. Regarding short-term risk, ICHR is more volatile compared to SMTC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SMTC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ONTO has a market cap of 13.6B. Regarding current trading prices, ICHR is priced at $72.58, while ONTO trades at $269.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ONTO's P/E ratio is 127.41. In terms of profitability, ICHR's ROE is -0.08%, compared to ONTO's ROE of +0.05%. Regarding short-term risk, ICHR is more volatile compared to ONTO. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ONTO's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AAOI has a market cap of 13.1B. Regarding current trading prices, ICHR is priced at $72.58, while AAOI trades at $170.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AAOI's P/E ratio is -250.58. In terms of profitability, ICHR's ROE is -0.08%, compared to AAOI's ROE of -0.06%. Regarding short-term risk, ICHR is more volatile compared to AAOI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AAOI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SWKS has a market cap of 11.1B. Regarding current trading prices, ICHR is priced at $72.58, while SWKS trades at $71.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SWKS's P/E ratio is 30.65. In terms of profitability, ICHR's ROE is -0.08%, compared to SWKS's ROE of +0.06%. Regarding short-term risk, ICHR is more volatile compared to SWKS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SWKS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, CREE has a market cap of 9.8B. Regarding current trading prices, ICHR is priced at $72.58, while CREE trades at $79.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas CREE's P/E ratio is N/A. In terms of profitability, ICHR's ROE is -0.08%, compared to CREE's ROE of -59.38%. Regarding short-term risk, ICHR is more volatile compared to CREE. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check CREE's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, FORM has a market cap of 9.4B. Regarding current trading prices, ICHR is priced at $72.58, while FORM trades at $115.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas FORM's P/E ratio is 138.64. In terms of profitability, ICHR's ROE is -0.08%, compared to FORM's ROE of +0.07%. Regarding short-term risk, ICHR is more volatile compared to FORM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check FORM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SIMO has a market cap of 8.7B. Regarding current trading prices, ICHR is priced at $72.58, while SIMO trades at $250.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SIMO's P/E ratio is 51.44. In terms of profitability, ICHR's ROE is -0.08%, compared to SIMO's ROE of +0.20%. Regarding short-term risk, ICHR is more volatile compared to SIMO. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SIMO's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ALGM has a market cap of 8.7B. Regarding current trading prices, ICHR is priced at $72.58, while ALGM trades at $44.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ALGM's P/E ratio is -582.87. In terms of profitability, ICHR's ROE is -0.08%, compared to ALGM's ROE of -0.02%. Regarding short-term risk, ICHR is more volatile compared to ALGM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ALGM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, QRVO has a market cap of 8.6B. Regarding current trading prices, ICHR is priced at $72.58, while QRVO trades at $96.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas QRVO's P/E ratio is 27.06. In terms of profitability, ICHR's ROE is -0.08%, compared to QRVO's ROE of +0.10%. Regarding short-term risk, ICHR is more volatile compared to QRVO. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check QRVO's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, CRUS has a market cap of 8.3B. Regarding current trading prices, ICHR is priced at $72.58, while CRUS trades at $158.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas CRUS's P/E ratio is 20.74. In terms of profitability, ICHR's ROE is -0.08%, compared to CRUS's ROE of +0.20%. Regarding short-term risk, ICHR is more volatile compared to CRUS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check CRUS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, VSH has a market cap of 8B. Regarding current trading prices, ICHR is priced at $72.58, while VSH trades at $54.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas VSH's P/E ratio is 5859.00. In terms of profitability, ICHR's ROE is -0.08%, compared to VSH's ROE of +0.00%. Regarding short-term risk, ICHR is more volatile compared to VSH. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check VSH's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, BRKS has a market cap of 7.8B. Regarding current trading prices, ICHR is priced at $72.58, while BRKS trades at $113.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas BRKS's P/E ratio is N/A. In terms of profitability, ICHR's ROE is -0.08%, compared to BRKS's ROE of -0.29%. Regarding short-term risk, ICHR is more volatile compared to BRKS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check BRKS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, CAMT has a market cap of 7.7B. Regarding current trading prices, ICHR is priced at $72.58, while CAMT trades at $167.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas CAMT's P/E ratio is 173.35. In terms of profitability, ICHR's ROE is -0.08%, compared to CAMT's ROE of +0.08%. Regarding short-term risk, ICHR is more volatile compared to CAMT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check CAMT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SLAB has a market cap of 7.2B. Regarding current trading prices, ICHR is priced at $72.58, while SLAB trades at $217.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SLAB's P/E ratio is -143.01. In terms of profitability, ICHR's ROE is -0.08%, compared to SLAB's ROE of -0.05%. Regarding short-term risk, ICHR is more volatile compared to SLAB. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SLAB's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MXL has a market cap of 6.5B. Regarding current trading prices, ICHR is priced at $72.58, while MXL trades at $71.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MXL's P/E ratio is -47.77. In terms of profitability, ICHR's ROE is -0.08%, compared to MXL's ROE of -0.28%. Regarding short-term risk, ICHR is more volatile compared to MXL. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MXL's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, NVTS has a market cap of 5.5B. Regarding current trading prices, ICHR is priced at $72.58, while NVTS trades at $21.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas NVTS's P/E ratio is -36.27. In terms of profitability, ICHR's ROE is -0.08%, compared to NVTS's ROE of -0.33%. Regarding short-term risk, ICHR is more volatile compared to NVTS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check NVTS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, KLIC has a market cap of 5.4B. Regarding current trading prices, ICHR is priced at $72.58, while KLIC trades at $102.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas KLIC's P/E ratio is 99.65. In terms of profitability, ICHR's ROE is -0.08%, compared to KLIC's ROE of +0.07%. Regarding short-term risk, ICHR is more volatile compared to KLIC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check KLIC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ACMR has a market cap of 5.2B. Regarding current trading prices, ICHR is priced at $72.58, while ACMR trades at $77.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ACMR's P/E ratio is 62.08. In terms of profitability, ICHR's ROE is -0.08%, compared to ACMR's ROE of +0.07%. Regarding short-term risk, ICHR is more volatile compared to ACMR. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ACMR's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ACLS has a market cap of 5.1B. Regarding current trading prices, ICHR is priced at $72.58, while ACLS trades at $155.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ACLS's P/E ratio is 51.11. In terms of profitability, ICHR's ROE is -0.08%, compared to ACLS's ROE of +0.10%. Regarding short-term risk, ICHR is more volatile compared to ACLS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ACLS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SYNA has a market cap of 5.1B. Regarding current trading prices, ICHR is priced at $72.58, while SYNA trades at $126.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SYNA's P/E ratio is -104.70. In terms of profitability, ICHR's ROE is -0.08%, compared to SYNA's ROE of -0.03%. Regarding short-term risk, ICHR is more volatile compared to SYNA. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SYNA's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, DIOD has a market cap of 4.8B. Regarding current trading prices, ICHR is priced at $72.58, while DIOD trades at $99.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas DIOD's P/E ratio is 55.95. In terms of profitability, ICHR's ROE is -0.08%, compared to DIOD's ROE of +0.05%. Regarding short-term risk, ICHR is more volatile compared to DIOD. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check DIOD's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, IPGP has a market cap of 4.5B. Regarding current trading prices, ICHR is priced at $72.58, while IPGP trades at $102.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas IPGP's P/E ratio is 156.43. In terms of profitability, ICHR's ROE is -0.08%, compared to IPGP's ROE of +0.01%. Regarding short-term risk, ICHR is more volatile compared to IPGP. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check IPGP's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, POWI has a market cap of 4.2B. Regarding current trading prices, ICHR is priced at $72.58, while POWI trades at $74.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas POWI's P/E ratio is 249.03. In terms of profitability, ICHR's ROE is -0.08%, compared to POWI's ROE of +0.02%. Regarding short-term risk, ICHR is more volatile compared to POWI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check POWI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, UCTT has a market cap of 4.1B. Regarding current trading prices, ICHR is priced at $72.58, while UCTT trades at $91.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas UCTT's P/E ratio is -21.42. In terms of profitability, ICHR's ROE is -0.08%, compared to UCTT's ROE of -0.28%. Regarding short-term risk, ICHR is more volatile compared to UCTT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check UCTT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, VECO has a market cap of 4.1B. Regarding current trading prices, ICHR is priced at $72.58, while VECO trades at $66.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas VECO's P/E ratio is 176.82. In terms of profitability, ICHR's ROE is -0.08%, compared to VECO's ROE of +0.03%. Regarding short-term risk, ICHR is more volatile compared to VECO. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check VECO's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, PI has a market cap of 3.8B. Regarding current trading prices, ICHR is priced at $72.58, while PI trades at $123.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas PI's P/E ratio is -139.08. In terms of profitability, ICHR's ROE is -0.08%, compared to PI's ROE of -0.14%. Regarding short-term risk, ICHR is more volatile compared to PI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check PI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AXTI has a market cap of 3.6B. Regarding current trading prices, ICHR is priced at $72.58, while AXTI trades at $85.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AXTI's P/E ratio is -244.87. In terms of profitability, ICHR's ROE is -0.08%, compared to AXTI's ROE of -0.06%. Regarding short-term risk, ICHR is more volatile compared to AXTI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AXTI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, LASR has a market cap of 3.6B. Regarding current trading prices, ICHR is priced at $72.58, while LASR trades at $62.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas LASR's P/E ratio is -211.60. In terms of profitability, ICHR's ROE is -0.08%, compared to LASR's ROE of -0.05%. Regarding short-term risk, ICHR is more volatile compared to LASR. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check LASR's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, HIMX has a market cap of 3.2B. Regarding current trading prices, ICHR is priced at $72.58, while HIMX trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas HIMX's P/E ratio is 96.16. In terms of profitability, ICHR's ROE is -0.08%, compared to HIMX's ROE of +0.04%. Regarding short-term risk, ICHR is more volatile compared to HIMX. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check HIMX's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AEHR has a market cap of 3B. Regarding current trading prices, ICHR is priced at $72.58, while AEHR trades at $94.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AEHR's P/E ratio is -248.18. In terms of profitability, ICHR's ROE is -0.08%, compared to AEHR's ROE of -0.09%. Regarding short-term risk, ICHR is more volatile compared to AEHR. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AEHR's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AMBA has a market cap of 2.9B. Regarding current trading prices, ICHR is priced at $72.58, while AMBA trades at $63.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AMBA's P/E ratio is -40.84. In terms of profitability, ICHR's ROE is -0.08%, compared to AMBA's ROE of -0.12%. Regarding short-term risk, ICHR is more volatile compared to AMBA. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AMBA's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, COHU has a market cap of 2.6B. Regarding current trading prices, ICHR is priced at $72.58, while COHU trades at $54.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas COHU's P/E ratio is -46.21. In terms of profitability, ICHR's ROE is -0.08%, compared to COHU's ROE of -0.07%. Regarding short-term risk, ICHR is more volatile compared to COHU. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check COHU's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, WOLF has a market cap of 2.4B. Regarding current trading prices, ICHR is priced at $72.58, while WOLF trades at $44.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas WOLF's P/E ratio is -3.68. In terms of profitability, ICHR's ROE is -0.08%, compared to WOLF's ROE of -52.09%. Regarding short-term risk, ICHR is more volatile compared to WOLF. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check WOLF's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, IMOS has a market cap of 2.1B. Regarding current trading prices, ICHR is priced at $72.58, while IMOS trades at $56.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas IMOS's P/E ratio is 73.22. In terms of profitability, ICHR's ROE is -0.08%, compared to IMOS's ROE of +0.03%. Regarding short-term risk, ICHR is more volatile compared to IMOS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check IMOS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, PLAB has a market cap of 1.7B. Regarding current trading prices, ICHR is priced at $72.58, while PLAB trades at $29.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas PLAB's P/E ratio is 10.91. In terms of profitability, ICHR's ROE is -0.08%, compared to PLAB's ROE of +0.13%. Regarding short-term risk, ICHR is more volatile compared to PLAB. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check PLAB's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SKYT has a market cap of 1.7B. Regarding current trading prices, ICHR is priced at $72.58, while SKYT trades at $35.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SKYT's P/E ratio is 15.02. In terms of profitability, ICHR's ROE is -0.08%, compared to SKYT's ROE of +0.75%. Regarding short-term risk, ICHR is more volatile compared to SKYT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SKYT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AMBQ has a market cap of 1.6B. Regarding current trading prices, ICHR is priced at $72.58, while AMBQ trades at $77.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AMBQ's P/E ratio is -16.53. In terms of profitability, ICHR's ROE is -0.08%, compared to AMBQ's ROE of -0.24%. Regarding short-term risk, ICHR is more volatile compared to AMBQ. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AMBQ's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AIP has a market cap of 1.6B. Regarding current trading prices, ICHR is priced at $72.58, while AIP trades at $33.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AIP's P/E ratio is -42.73. In terms of profitability, ICHR's ROE is -0.08%, compared to AIP's ROE of +4.46%. Regarding short-term risk, ICHR is more volatile compared to AIP. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AIP's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, POET has a market cap of 1.4B. Regarding current trading prices, ICHR is priced at $72.58, while POET trades at $11.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas POET's P/E ratio is -12.82. In terms of profitability, ICHR's ROE is -0.08%, compared to POET's ROE of -0.44%. Regarding short-term risk, ICHR is more volatile compared to POET. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check POET's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, AOSL has a market cap of 1.2B. Regarding current trading prices, ICHR is priced at $72.58, while AOSL trades at $38.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas AOSL's P/E ratio is -11.40. In terms of profitability, ICHR's ROE is -0.08%, compared to AOSL's ROE of -0.13%. Regarding short-term risk, ICHR is more volatile compared to AOSL. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check AOSL's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, CEVA has a market cap of 1.2B. Regarding current trading prices, ICHR is priced at $72.58, while CEVA trades at $41.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas CEVA's P/E ratio is -93.61. In terms of profitability, ICHR's ROE is -0.08%, compared to CEVA's ROE of -0.04%. Regarding short-term risk, ICHR is more volatile compared to CEVA. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check CEVA's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, SGH has a market cap of 1.1B. Regarding current trading prices, ICHR is priced at $72.58, while SGH trades at $20.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas SGH's P/E ratio is -24.53. In terms of profitability, ICHR's ROE is -0.08%, compared to SGH's ROE of +0.12%. Regarding short-term risk, ICHR is more volatile compared to SGH. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check SGH's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, INDI has a market cap of 849.4M. Regarding current trading prices, ICHR is priced at $72.58, while INDI trades at $4.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas INDI's P/E ratio is -5.29. In terms of profitability, ICHR's ROE is -0.08%, compared to INDI's ROE of -0.42%. Regarding short-term risk, ICHR is more volatile compared to INDI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check INDI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, QNC has a market cap of 642.8M. Regarding current trading prices, ICHR is priced at $72.58, while QNC trades at $2.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas QNC's P/E ratio is N/A. In terms of profitability, ICHR's ROE is -0.08%, compared to QNC's ROE of -0.36%. Regarding short-term risk, ICHR is more volatile compared to QNC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check QNC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MRAM has a market cap of 545.9M. Regarding current trading prices, ICHR is priced at $72.58, while MRAM trades at $23.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MRAM's P/E ratio is 2328.00. In terms of profitability, ICHR's ROE is -0.08%, compared to MRAM's ROE of +0.00%. Regarding short-term risk, ICHR is more volatile compared to MRAM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MRAM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, NVEC has a market cap of 508.7M. Regarding current trading prices, ICHR is priced at $72.58, while NVEC trades at $104.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas NVEC's P/E ratio is 33.49. In terms of profitability, ICHR's ROE is -0.08%, compared to NVEC's ROE of +0.26%. Regarding short-term risk, ICHR is more volatile compared to NVEC. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check NVEC's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, LAES has a market cap of 439.2M. Regarding current trading prices, ICHR is priced at $72.58, while LAES trades at $3.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas LAES's P/E ratio is -12.83. In terms of profitability, ICHR's ROE is -0.08%, compared to LAES's ROE of -0.12%. Regarding short-term risk, ICHR is more volatile compared to LAES. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check LAES's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, XPER has a market cap of 366.9M. Regarding current trading prices, ICHR is priced at $72.58, while XPER trades at $7.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas XPER's P/E ratio is -7.68. In terms of profitability, ICHR's ROE is -0.08%, compared to XPER's ROE of -0.10%. Regarding short-term risk, ICHR is more volatile compared to XPER. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check XPER's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, QUIK has a market cap of 349.2M. Regarding current trading prices, ICHR is priced at $72.58, while QUIK trades at $18.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas QUIK's P/E ratio is -26.27. In terms of profitability, ICHR's ROE is -0.08%, compared to QUIK's ROE of -0.60%. Regarding short-term risk, ICHR is more volatile compared to QUIK. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check QUIK's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, TGAN has a market cap of 323.1M. Regarding current trading prices, ICHR is priced at $72.58, while TGAN trades at $5.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas TGAN's P/E ratio is -7.29. In terms of profitability, ICHR's ROE is -0.08%, compared to TGAN's ROE of -1.24%. Regarding short-term risk, ICHR is more volatile compared to TGAN. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check TGAN's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ALMU has a market cap of 319.7M. Regarding current trading prices, ICHR is priced at $72.58, while ALMU trades at $22.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ALMU's P/E ratio is -64.46. In terms of profitability, ICHR's ROE is -0.08%, compared to ALMU's ROE of -0.17%. Regarding short-term risk, ICHR is more volatile compared to ALMU. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ALMU's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ASYS has a market cap of 276.5M. Regarding current trading prices, ICHR is priced at $72.58, while ASYS trades at $19.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ASYS's P/E ratio is 105.94. In terms of profitability, ICHR's ROE is -0.08%, compared to ASYS's ROE of +0.04%. Regarding short-term risk, ICHR is more volatile compared to ASYS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ASYS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ATOM has a market cap of 261.6M. Regarding current trading prices, ICHR is priced at $72.58, while ATOM trades at $8.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ATOM's P/E ratio is -12.38. In terms of profitability, ICHR's ROE is -0.08%, compared to ATOM's ROE of -0.85%. Regarding short-term risk, ICHR is more volatile compared to ATOM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ATOM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, VLN has a market cap of 229M. Regarding current trading prices, ICHR is priced at $72.58, while VLN trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas VLN's P/E ratio is -7.02. In terms of profitability, ICHR's ROE is -0.08%, compared to VLN's ROE of -0.29%. Regarding short-term risk, ICHR is more volatile compared to VLN. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check VLN's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, MX has a market cap of 228.8M. Regarding current trading prices, ICHR is priced at $72.58, while MX trades at $6.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas MX's P/E ratio is -15.32. In terms of profitability, ICHR's ROE is -0.08%, compared to MX's ROE of -0.10%. Regarding short-term risk, ICHR is more volatile compared to MX. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check MX's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, GSIT has a market cap of 222.6M. Regarding current trading prices, ICHR is priced at $72.58, while GSIT trades at $7.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas GSIT's P/E ratio is -18.17. In terms of profitability, ICHR's ROE is -0.08%, compared to GSIT's ROE of -0.22%. Regarding short-term risk, ICHR is more volatile compared to GSIT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check GSIT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, INTT has a market cap of 197.3M. Regarding current trading prices, ICHR is priced at $72.58, while INTT trades at $15.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas INTT's P/E ratio is 392.50. In terms of profitability, ICHR's ROE is -0.08%, compared to INTT's ROE of +0.01%. Regarding short-term risk, ICHR is more volatile compared to INTT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check INTT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, BZAI has a market cap of 179.5M. Regarding current trading prices, ICHR is priced at $72.58, while BZAI trades at $1.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas BZAI's P/E ratio is -2.87. In terms of profitability, ICHR's ROE is -0.08%, compared to BZAI's ROE of -5.37%. Regarding short-term risk, ICHR is more volatile compared to BZAI. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check BZAI's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, VLN-WT has a market cap of 159M. Regarding current trading prices, ICHR is priced at $72.58, while VLN-WT trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas VLN-WT's P/E ratio is N/A. In terms of profitability, ICHR's ROE is -0.08%, compared to VLN-WT's ROE of -0.29%. Regarding short-term risk, ICHR is more volatile compared to VLN-WT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check VLN-WT's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, GCTS has a market cap of 147.9M. Regarding current trading prices, ICHR is priced at $72.58, while GCTS trades at $2.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas GCTS's P/E ratio is -3.15. In terms of profitability, ICHR's ROE is -0.08%, compared to GCTS's ROE of +0.60%. Regarding short-term risk, ICHR is more volatile compared to GCTS. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check GCTS's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, OIIM has a market cap of 143M. Regarding current trading prices, ICHR is priced at $72.58, while OIIM trades at $4.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas OIIM's P/E ratio is 27.22. In terms of profitability, ICHR's ROE is -0.08%, compared to OIIM's ROE of +0.13%. Regarding short-term risk, ICHR is more volatile compared to OIIM. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check OIIM's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, NA has a market cap of 131.3M. Regarding current trading prices, ICHR is priced at $72.58, while NA trades at $1.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas NA's P/E ratio is 1.93. In terms of profitability, ICHR's ROE is -0.08%, compared to NA's ROE of N/A. Regarding short-term risk, ICHR is less volatile compared to NA. This indicates potentially lower risk in terms of short-term price fluctuations for ICHR.Check NA's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, ARBE has a market cap of 104.3M. Regarding current trading prices, ICHR is priced at $72.58, while ARBE trades at $0.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas ARBE's P/E ratio is -2.30. In terms of profitability, ICHR's ROE is -0.08%, compared to ARBE's ROE of -0.86%. Regarding short-term risk, ICHR is more volatile compared to ARBE. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check ARBE's competition here

ICHR plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICHR stands at 2.5B. In comparison, TRT has a market cap of 99.6M. Regarding current trading prices, ICHR is priced at $72.58, while TRT trades at $9.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICHR currently has a P/E ratio of -48.38, whereas TRT's P/E ratio is 246.25. In terms of profitability, ICHR's ROE is -0.08%, compared to TRT's ROE of +0.01%. Regarding short-term risk, ICHR is more volatile compared to TRT. This indicates potentially higher risk in terms of short-term price fluctuations for ICHR.Check TRT's competition here